Categories
medical Strategic

Strategic Collaboration Memorandum between EC Healthcare and China Medical System Utilizes the Synergy of Upstream and Downstream of the Aesthetic Medical Industry, Promotes the Development of Medical Products and Talents

HONG KONG, June 11, 2021 – (ACN Newswire) – EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* and China Medical System Holdings Limited (the “CMS”, SEHK stock code: 867), jointly announce that the Group and a…

HONG KONG, June 11, 2021 – (ACN Newswire) – EC Healthcare (the”Company”, which together with its subsidiaries is referred to as the”Group”, SEHK stock code: 2138), the largest non-hospital medical team in Hong Kongand China Medical System Holdings Limited (the”CMS”, SEHK stock code: 867), jointly announce the Group and a subsidiary of the CMS entered into a memorandum in connection to the strategiccollaboration, including but not restricted to setting up an aesthetic medical advertising centre for distribution and marketing of aesthetics medication and related products initially in Hong Kong, also researching to prepare an aesthetic medical training and education platform for registered practitioners, and further exploring the creation of a nationally aesthetic medical doctor partnership business platform.

The Group is the largest non-hospital medical service provider in Hong Kong located in the Greater Bay Area, providing medical, cosmetic medical and health care services. The CMS Group is an innovation-driven specialty pharma having a focus on sales and marketing in China, with more than two decades demonstrated record of experience in successful drug promotion in multi departments. Of vertical advancement in the specialist area, the CMS Group is constantly expanding its flat boundary at the same and deploy product matrix in major skin direction and medical cosmetic technology. According to the memorandum, the Group and CMS will setup and run a cosmetic medical marketing center in Hong Kong as starting point for supply, sales and promotion of aesthetics medication and related products in Hong Kong, set up an aesthetic medical training and education platform for registered practitioners to present aesthetic medical services, and further explore the creation of a nationwide aesthetic medical doctor venture business platform, to be able to strategically join upstream and downstream of aesthetic medical industry to maximize the market synergy, encourage the compliance with aesthetic medical products, cultivate the commercialisation of aesthetic medical professionals, and standardize aesthetic health services.

Under the strategic alliance, CMS plans to inject the medication resources on its research and development platform as well as the supply rights of aesthetic medication or associated goods in Hong Kong; EC Healthcare intends to inject its electronic marketing strategy, group of registered practitioners, sources of key opinion leaders and celebrity spokespersons and its own branding influence for a industry leader in the business. Besides, by minding CMS’s vast network of healthcare professionals in the China and EC Healthcare’s aesthetic medical education expertise, the parties will establish as an education and training centre for bettering and certifying a new generation of aesthetic medical abilities, and actively explore the formation of a nationally aesthetic medical doctor partnership business platform.

Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare stated,”The Group is honored to establish a long-term strategic partnership with CMS. Both parties will fully exploit their respective advantages to realize a strong alliance. In the past few years, EC Healthcare’s outstanding performance continued to prove the Group’s brand power and operational capabilities in the Greater Bay Area and across the country. Through the collaboration, we hope to facilitate the Group’s precise layout in mainland market and scale the aesthetic medical business to a new height through replicating the successful operation system. In light of the strong growth potential of China’s aesthetic medical services market, as well as the shortage of compliant aesthetics medication and talents, the Group believes that the collaboration can promote valuable synergies between the upstream and downstream of the industry, thereby leading the development of pharmaceuticals and medical talents in order to reform the industry and resolve the pain points in response to the strong domestic demand for high-quality compliant aesthetic medical services.”

About EC Healthcare
EC Healthcare is Hong Kong’s largest non-hospital medical service supplier *, minding its core companies of preventive and precision medication, and committed to

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *